Your browser doesn't support javascript.
loading
Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19).
Ullah, Sami; Abid, Radhya; Haider, Sana; Khuda, Fazli; Albadrani, Ghadeer M; Abdulhakim, Jawaher A; Altyar, Ahmed E; Abdel-Daim, Mohamed M; Halimi, Syed Muhammad Ashhad; Khalil, Atif Ali Khan.
Afiliación
  • Ullah S; Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
  • Abid R; Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
  • Haider S; Department of Pharmacy, CECOS University of Science and Technology, Peshawar 25120, Pakistan.
  • Khuda F; Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
  • Albadrani GM; Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
  • Abdulhakim JA; Medical Laboratory Department, College of Applied Medical Sciences, Taibah University, Yanbu 46522, Saudi Arabia.
  • Altyar AE; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Abdel-Daim MM; Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
  • Halimi SMA; Department of Pharmacology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt.
  • Khalil AAK; Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
Medicina (Kaunas) ; 58(8)2022 Aug 10.
Article en En | MEDLINE | ID: mdl-36013543

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Pakistán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Pakistán